Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | DEPTOR | Q8TB45 | 2/20 | 0.34 |
| ▸ | GAA | P10253 | 4/20 | 0.33 |
| ▸ | MEN1 | O00255 | 3/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.33 |
| ▸ | MAPT | P10636 | 3/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | GFER | P55789 | 3/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL923504 | 0.75 | ALDH1A1 (0.46) | ALDH1A1DEPTORGAAMEN1KMT2A | |
| SCHEMBL922697 | 0.60 | DEPTOR (0.44) | ALDH1A1DEPTORGAAMEN1KMT2A | |
| SCHEMBL550762 | 0.59 | ALDH1A1 (0.61) | ALDH1A1DEPTORGAAMEN1KMT2A | |
| SCHEMBL924332 | 0.58 | MAPT (0.46) | DEPTORGAAMEN1KMT2AMAPT | |
| SCHEMBL922745 | 0.58 | MAPT (0.53) | ALDH1A1DEPTORGAAMEN1KMT2A | |
| SCHEMBL922087 | 0.58 | ALDH1A1 (0.38) | ALDH1A1DEPTORGAAMEN1KMT2A | |
| SCHEMBL923847 | 0.58 | DEPTOR (0.60) | ALDH1A1DEPTORGAAMEN1KMT2A | |
| SCHEMBL921999 | 0.58 | ALDH1A1 (0.46) | ALDH1A1DEPTORGAAMEN1KMT2A | |
| SCHEMBL922314 | 0.57 | MAPT (0.48) | ALDH1A1DEPTORGAAMEN1KMT2A | |
| SCHEMBL922071 | 0.57 | DEPTOR (0.53) | ALDH1A1DEPTORGAAMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230321043-A1 | COMPOUNDS HAVING PSEUDOMONAS ANTI-BIOFILM PROPERTIES | UNIV COPENHAGEN (DK) | 2023-10-12 | — | — | US | disclosed |
| US-20230321043-A1 | COMPOUNDS HAVING PSEUDOMONAS ANTI-BIOFILM PROPERTIES | UNIV COPENHAGEN (DK) | 2023-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230321043-A1 | COMPOUNDS HAVING PSEUDOMONAS ANTI-BIOFILM PROPERTIES | GMPS, PDE11A, CGAS | ALDH1A1 3702/4885DEPTOR 1931/4885GAA 637/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.